CUSIP: 29428V104
Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
77,877,065
-
Share change
-
+11,695,046
-
Total reported value
-
$964,818,171
-
Put/Call ratio
-
179%
-
Price per share
-
$12.39
-
Number of holders
-
118
-
Value change
-
+$158,642,546
-
Number of buys
-
74
-
Number of sells
-
47
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2019
-
Previous quarter:
Q4 2018
Recent filing periods for CUSIP 29428V104:
Institutional Holders of EPIZYME INC - COM (EPZM) as of Q1 2019
As of 31 Mar 2019,
EPIZYME INC - COM (EPZM) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,877,065 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Redmile Group, LLC, Palo Alto Investors LP, NEA Management Company, LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Consonance Capital Management LP, STATE STREET CORP, and GREAT POINT PARTNERS LLC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.